Bain Capital Life Sciences Investors, LLC Q1 2019 Filing

Filed May 15, 2019

Portfolio Value

$250.1B

Holdings

6

Report Date

Q1 2019

Filing Type

13F-HR

All Holdings (6 positions)

#StockSharesValue% PortfolioType
1
—DICERNA PHARMACEUTICALS INC
8,930,237$130.8B52.31%
2
REPLREPLIMUNE GROUP INC
2,838,968$43.2B17.28%
3
IFRXINFLARX NV
732,670$27.7B11.07%
4
—MARINUS PHARMACEUTICALS INC
5,042,735$21.1B8.43%
5
SLDBSOLID BIOSCIENCES INC
1,989,444$18.3B7.32%
6
—APTINYX INC
2,225,092$9.0B3.60%